SCHEMBL26317140

SCHEMBL26317140

CS(=O)(=O)OC1CCN(OC(=O)c2ccccc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.49
MEN1 O00255 1/20 0.49
SCN1A P35498 1/20 0.43
SCN2A Q99250 1/20 0.43
SCN3A Q9NY46 1/20 0.43
CARM1 Q86X55 2/20 0.42
PRMT6 Q96LA8 2/20 0.42
CHRNA7 P36544 2/20 0.42
CHRNB2 P17787 1/20 0.42
CHRNA5 P30532 1/20 0.42
CHRNA4 P43681 1/20 0.42
HTR3E A5X5Y0 1/20 0.42
HTR3B O95264 1/20 0.42
HTR3A P46098 1/20 0.42
HTR3D Q70Z44 1/20 0.42
HTR3C Q8WXA8 1/20 0.42
TSHR P16473 2/20 0.41
APOBEC3A P31941 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
CHRM3 P20309 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26019479 0.81 CHRNA7 (0.40) KMT2AMEN1CHRNA7HTR3EHTR3B
SCHEMBL29346476 0.81 CHRNA7 (0.40) KMT2AMEN1CHRNA7HTR3EHTR3B
SCHEMBL26019255 0.81 CHRNA7 (0.40) KMT2AMEN1CHRNA7HTR3EHTR3B
SCHEMBL18821943 0.81 KMT2A (0.46) KMT2AMEN1SCN1ASCN2ASCN3A
SCHEMBL12538923 0.80 ACHE (0.60) KMT2AMEN1GAA
SCHEMBL27624527 0.79 ACHE (0.58) KMT2AMEN1CHRNA7CHRNB2CHRNA5
SCHEMBL27781385 0.77 KMT2A (0.46) KMT2AMEN1SCN1ASCN2ASCN3A
SCHEMBL26317202 0.77 KMT2A (0.41) KMT2AMEN1SCN1ASCN2ASCN3A
SCHEMBL26317141 0.77 KMT2A (0.41) KMT2AMEN1SCN1ASCN2ASCN3A
SCHEMBL25629349 0.77 KMT2A (0.47) KMT2AMEN1SCN1ASCN2ASCN3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023249968-A1 BIFUNCTIONAL COMPOUNDS CONTAINING PYRIDO[2,3-DJPYRIMIDIN-7(8H)-ONE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 VIA UBIQUITIN PROTEASOME PATHWAY NIKANG THERAPEUTICS, INC. (US) 2023-12-28 WO disclosed
WO-2023156311-A1 PROCESSES FOR THE PREPARATION OF 1,2,3,5,6,7-HEXAHYDRO-S-INDACENE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2023-08-24 WO disclosed